• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性淋巴结清扫术对I型与II型子宫内膜癌患者生存的不同影响:一项回顾性观察队列研究

Differential Impact of Systemic Lymphadenectomy Upon the Survival of Patients with Type I vs Type II Endometrial Cancer: A Retrospective Observational Cohort Study.

作者信息

Xu Jie, Chen Can, Xiong Jing, Linghu Hua

机构信息

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People's Republic of China.

The First Clinical College, Chongqing Medical University, Chongqing 400016, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Nov 30;12:12269-12276. doi: 10.2147/CMAR.S280780. eCollection 2020.

DOI:10.2147/CMAR.S280780
PMID:33299347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7721119/
Abstract

PURPOSE

To determine whether systemic lymphadenectomy exerts a similar effect on the survival of patients with either type I or type II endometrial cancer (EC).

PATIENTS AND METHODS

In this retrospective study, 682 eligible patients diagnosed with EC were typed according to the pathological reports. The thoroughness of lymphadenectomy was evaluated by the lymph node number of which the cut-off value was determined by the receiver operator characteristic (ROC) curve and Youden index. The impact of thoroughness on the survival of both types was analyzed, respectively, by Kaplan Meier (K-M) method and further evaluated in subgroups with and without lymphatic metastasis. Independent prognostic factors of survival were selected by proportional hazard regression (Cox) model.

RESULTS

The cut-off level of lymph node number was 20. The differential impact of the lymph node number removed on survival was noted when patients with different types were analyzed separately. Among type II EC, those with >20 lymph nodes removed presented better overall survival (OS) than those with ≤20 (=0.002). The number of lymph nodes removed >20 was proved as an independent factor for improved OS in type II EC (HR=0.329,95% CI: 0.123-0.881, =0.0027). In the subgroup of type II with >20 lymph nodes resected, similar 5-year OS rates were observed in those with or without identified positive node (90.9% vs 92.9%, =0.965). Type I EC seemed unbeneficial from such a procedure.

CONCLUSION

Systemic lymphadenectomy could enhance the OS of type II EC other than type I.

摘要

目的

确定系统性淋巴结清扫术对Ⅰ型或Ⅱ型子宫内膜癌(EC)患者的生存是否具有相似的影响。

患者与方法

在这项回顾性研究中,根据病理报告对682例确诊为EC的合格患者进行分型。通过淋巴结数量评估淋巴结清扫的彻底性,其临界值由受试者工作特征(ROC)曲线和尤登指数确定。分别采用Kaplan-Meier(K-M)法分析清扫彻底性对两种类型患者生存的影响,并在有或无淋巴转移的亚组中进一步评估。通过比例风险回归(Cox)模型选择生存的独立预后因素。

结果

淋巴结数量的临界水平为20。分别分析不同类型患者时,发现切除的淋巴结数量对生存有不同影响。在Ⅱ型EC中,切除淋巴结>20个的患者总生存期(OS)优于切除淋巴结≤20个的患者(P=0.002)。切除淋巴结>20个被证明是Ⅱ型EC患者OS改善的独立因素(HR=0.329,95%CI:0.123-0.881,P=0.0027)。在切除淋巴结>20个的Ⅱ型亚组中,有无阳性淋巴结的患者5年OS率相似(90.9%对92.9%,P=0.965)。Ⅰ型EC似乎未从此类手术中获益。

结论

系统性淋巴结清扫术可提高Ⅱ型而非Ⅰ型EC的OS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd64/7721119/5975c7a89d45/CMAR-12-12269-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd64/7721119/f1dee81f1e32/CMAR-12-12269-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd64/7721119/c5531395d1e3/CMAR-12-12269-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd64/7721119/5975c7a89d45/CMAR-12-12269-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd64/7721119/f1dee81f1e32/CMAR-12-12269-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd64/7721119/c5531395d1e3/CMAR-12-12269-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd64/7721119/5975c7a89d45/CMAR-12-12269-g0003.jpg

相似文献

1
Differential Impact of Systemic Lymphadenectomy Upon the Survival of Patients with Type I vs Type II Endometrial Cancer: A Retrospective Observational Cohort Study.系统性淋巴结清扫术对I型与II型子宫内膜癌患者生存的不同影响:一项回顾性观察队列研究
Cancer Manag Res. 2020 Nov 30;12:12269-12276. doi: 10.2147/CMAR.S280780. eCollection 2020.
2
Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.基于盆腔淋巴结清扫彻底程度对子宫内膜样型子宫内膜癌中高危组生存影响的多中心回顾性队列分析。
Gynecol Oncol. 2016 Jun;141(3):440-446. doi: 10.1016/j.ygyno.2016.03.031. Epub 2016 Apr 8.
3
Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.高危型子宫内膜癌患者行前哨淋巴结评估与全面淋巴结清扫术的结局比较。
Gynecol Oncol. 2023 Jul;174:273-277. doi: 10.1016/j.ygyno.2023.05.002. Epub 2023 Jun 2.
4
Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.老年Ⅰ期子宫内膜样腺癌女性的淋巴结切除术与预后。
Arch Gynecol Obstet. 2019 Sep;300(3):683-691. doi: 10.1007/s00404-019-05225-6. Epub 2019 Jun 29.
5
Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer: Time to move from personalized cancer medicine to personalized patient medicine!老年中高危、高危或晚期子宫内膜癌患者的淋巴结切除术:是时候从个体化癌症医学转向个体化患者医学了!
Eur J Surg Oncol. 2019 Aug;45(8):1388-1395. doi: 10.1016/j.ejso.2019.02.015. Epub 2019 Feb 18.
6
Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.骨骼肌指数和全身炎症指数对淋巴结阳性乳腺癌根治术后患者的预后意义。
BMC Cancer. 2022 Mar 3;22(1):234. doi: 10.1186/s12885-022-09312-x.
7
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.淋巴结比率和临床病理参数对 IIIC 期子宫内膜癌患者的预后价值。
Obstet Gynecol. 2012 Jun;119(6):1210-8. doi: 10.1097/AOG.0b013e318255060c.
8
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.根治性膀胱切除术联合盆腔淋巴结整块清扫术后盆腔淋巴结转移患者的危险因素:淋巴结密度概念
J Urol. 2003 Jul;170(1):35-41. doi: 10.1097/01.ju.0000072422.69286.0e.
9
Disease-Free and Overall Survival Implications of Pelvic Lymphadenectomy in Endometrial Cancer: A Retrospective Population-Based Single-Center Study.子宫内膜癌盆腔淋巴结清扫术对无病生存期和总生存期的影响:一项基于人群的回顾性单中心研究
Cancers (Basel). 2023 Nov 29;15(23):5636. doi: 10.3390/cancers15235636.
10
Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study.子宫内膜癌中通过淋巴结清扫术与前哨淋巴结活检进行手术分期后的总生存期:一项国家癌症数据库研究
Int J Gynecol Cancer. 2022 Jan;32(1):28-40. doi: 10.1136/ijgc-2021-002927. Epub 2021 Nov 8.

引用本文的文献

1
Recent management of endometrial cancer: a narrative review of the literature.子宫内膜癌的近期管理:文献综述
Front Med (Lausanne). 2024 Jan 3;10:1244634. doi: 10.3389/fmed.2023.1244634. eCollection 2023.
2
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer.泛亚地区适应性欧洲肿瘤内科学会(ESMO)子宫内膜癌诊断、治疗和随访临床实践指南。
ESMO Open. 2023 Feb;8(1):100774. doi: 10.1016/j.esmoop.2022.100774. Epub 2023 Jan 23.

本文引用的文献

1
Correlation between pre-operative and final histological diagnosis on endometrial cancer.子宫内膜癌术前与最终组织学诊断的相关性。
Int J Gynecol Cancer. 2019 Jun;29(5):886-889. doi: 10.1136/ijgc-2018-000041. Epub 2019 Jan 4.
2
Comparison of laparoscopic surgery and conventional laparotomy for surgical staging of patients with presumed low-risk endometrial cancer: The current state of Japan.腹腔镜手术与传统开腹手术用于疑似低风险子宫内膜癌患者手术分期的比较:日本的现状
Taiwan J Obstet Gynecol. 2019 Jan;58(1):99-104. doi: 10.1016/j.tjog.2018.11.019.
3
Cancer statistics, 2019.
癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
4
Prospective study of sentinel lymph node mapping for endometrial cancer.子宫内膜癌前哨淋巴结绘图的前瞻性研究。
Int J Gynaecol Obstet. 2018 Dec;143(3):313-318. doi: 10.1002/ijgo.12651. Epub 2018 Sep 19.
5
Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience.高级别子宫内膜癌的临床病理和生存特征比较;单中心经验。
Curr Probl Cancer. 2019 Apr;43(2):160-166. doi: 10.1016/j.currproblcancer.2018.07.004. Epub 2018 Jul 21.
6
Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.提高子宫内膜癌吲哚菁绿前哨淋巴结定位的技巧。
Gynecol Oncol. 2018 Aug;150(2):267-273. doi: 10.1016/j.ygyno.2018.06.001. Epub 2018 Jun 15.
7
Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.分期淋巴结切除术对非子宫内膜样子宫内膜癌的生存意义。
Gynecol Oncol. 2018 Jun;149(3):531-538. doi: 10.1016/j.ygyno.2018.03.046. Epub 2018 Mar 17.
8
Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.早期子宫内膜癌中无淋巴结转移时淋巴管浸润的预后意义。
Int J Gynecol Cancer. 2018 Jun;28(5):890-894. doi: 10.1097/IGC.0000000000001229.
9
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer.组织学评估和分子/基因组分析在子宫内膜癌管理中的作用演变。
J Natl Compr Canc Netw. 2018 Feb;16(2):201-209. doi: 10.6004/jnccn.2017.7066.
10
Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.前哨淋巴结(SLN)图谱在高危子宫内膜癌中的应用
Gynecol Oncol. 2017 Dec;147(3):549-553. doi: 10.1016/j.ygyno.2017.09.014. Epub 2017 Sep 22.